We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
Updated: 10/20/2017
The Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) Study
Status: Enrolling
Updated: 10/20/2017
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
Updated: 10/20/2017
The Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) Study
Status: Enrolling
Updated: 10/20/2017
Click here to add this to my saved trials
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
Updated: 10/20/2017
The Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) Study
Status: Enrolling
Updated: 10/20/2017
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
Updated: 10/20/2017
The Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) Study
Status: Enrolling
Updated: 10/20/2017
Click here to add this to my saved trials
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
Updated: 10/20/2017
The Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) Study
Status: Enrolling
Updated: 10/20/2017
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
Updated: 10/20/2017
The Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) Study
Status: Enrolling
Updated: 10/20/2017
Click here to add this to my saved trials
Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Updated: 10/20/2017
Treatment of Hepatic Encephalopathy With Benzodiazepine Antagonist (Flumazenil) and Change in Cortical GABA Levels in Localized 1H-MR Spectroscopy
Status: Enrolling
Updated: 10/20/2017
Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Updated: 10/20/2017
Treatment of Hepatic Encephalopathy With Benzodiazepine Antagonist (Flumazenil) and Change in Cortical GABA Levels in Localized 1H-MR Spectroscopy
Status: Enrolling
Updated: 10/20/2017
Click here to add this to my saved trials
T-ABA Group Based Early Intervention For Parents of Children With ASD
Updated: 10/20/2017
Targeted Applied Behavior Analysis (T-ABA) Group Based Early Intervention for Parents of Children With Autism Spectrum Disorder (ASD)
Status: Enrolling
Updated: 10/20/2017
T-ABA Group Based Early Intervention For Parents of Children With ASD
Updated: 10/20/2017
Targeted Applied Behavior Analysis (T-ABA) Group Based Early Intervention for Parents of Children With Autism Spectrum Disorder (ASD)
Status: Enrolling
Updated: 10/20/2017
Click here to add this to my saved trials
Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Updated: 10/20/2017
A Study to Preliminarily Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Status: Enrolling
Updated: 10/20/2017
Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Updated: 10/20/2017
A Study to Preliminarily Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Status: Enrolling
Updated: 10/20/2017
Click here to add this to my saved trials
Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Updated: 10/20/2017
A Study to Preliminarily Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Status: Enrolling
Updated: 10/20/2017
Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Updated: 10/20/2017
A Study to Preliminarily Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Status: Enrolling
Updated: 10/20/2017
Click here to add this to my saved trials
Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Updated: 10/20/2017
A Study to Preliminarily Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Status: Enrolling
Updated: 10/20/2017
Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Updated: 10/20/2017
A Study to Preliminarily Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Status: Enrolling
Updated: 10/20/2017
Click here to add this to my saved trials
Novel Protection Against Potential Brain, Hearing and Vision Injury During Blast Wave Exposure
Updated: 10/20/2017
Novel Protection Against Potential Brain, Hearing and Vision Injury During Blast Wave Exposure
Status: Enrolling
Updated: 10/20/2017
Novel Protection Against Potential Brain, Hearing and Vision Injury During Blast Wave Exposure
Updated: 10/20/2017
Novel Protection Against Potential Brain, Hearing and Vision Injury During Blast Wave Exposure
Status: Enrolling
Updated: 10/20/2017
Click here to add this to my saved trials
Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
Updated: 10/22/2017
Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
Status: Enrolling
Updated: 10/22/2017
Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
Updated: 10/22/2017
Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
Status: Enrolling
Updated: 10/22/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Updated: 10/23/2017
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Click here to add this to my saved trials
Bilateral Versus Unilateral Task Retraining Using the SaeboFlex Orthosis
Updated: 10/24/2017
The Effectiveness of Bilateral Versus Unilateral Task Retraining Using the SaeboFlex Orthosis in Individuals With Subacute and Chronic Stroke.
Status: Enrolling
Updated: 10/24/2017
Bilateral Versus Unilateral Task Retraining Using the SaeboFlex Orthosis
Updated: 10/24/2017
The Effectiveness of Bilateral Versus Unilateral Task Retraining Using the SaeboFlex Orthosis in Individuals With Subacute and Chronic Stroke.
Status: Enrolling
Updated: 10/24/2017
Click here to add this to my saved trials
Primed vs. Unprimed rTMS in Chronic Stroke
Updated: 10/24/2017
6-Hz Primed vs. Unprimed Low-Frequency rTMS in Chronic Stroke
Status: Enrolling
Updated: 10/24/2017
Primed vs. Unprimed rTMS in Chronic Stroke
Updated: 10/24/2017
6-Hz Primed vs. Unprimed Low-Frequency rTMS in Chronic Stroke
Status: Enrolling
Updated: 10/24/2017
Click here to add this to my saved trials
Home-based Non-invasive Brain Stimulation and Hand Tracking Rehabilitation for People With Chronic Stroke
Updated: 10/24/2017
Home-based tDCS and Hand Tracking Rehabilitation for Chronic Stroke
Status: Enrolling
Updated: 10/24/2017
Home-based Non-invasive Brain Stimulation and Hand Tracking Rehabilitation for People With Chronic Stroke
Updated: 10/24/2017
Home-based tDCS and Hand Tracking Rehabilitation for Chronic Stroke
Status: Enrolling
Updated: 10/24/2017
Click here to add this to my saved trials
Spreading Depolarization and Ketamine Suppression
Updated: 10/24/2017
Spreading Depolarization and Ketamine Suppression
Status: Enrolling
Updated: 10/24/2017
Spreading Depolarization and Ketamine Suppression
Updated: 10/24/2017
Spreading Depolarization and Ketamine Suppression
Status: Enrolling
Updated: 10/24/2017
Click here to add this to my saved trials
Traumatic Brain Injury and Effects of Acute Cyclosporine A
Updated: 10/24/2017
Oxidative Damage and Calcium-Activated Proteolytic Biomarkers After Traumatic Brain Injury and Effects of Acute Cyclosporine A
Status: Enrolling
Updated: 10/24/2017
Traumatic Brain Injury and Effects of Acute Cyclosporine A
Updated: 10/24/2017
Oxidative Damage and Calcium-Activated Proteolytic Biomarkers After Traumatic Brain Injury and Effects of Acute Cyclosporine A
Status: Enrolling
Updated: 10/24/2017
Click here to add this to my saved trials
A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy
Updated: 10/25/2017
Is Autologous Umbilical Cord Blood Reinfusion Beneficial in Children With Cerebral Palsy: A Randomized, Blinded, Placebo-Controlled, Crossover Study
Status: Enrolling
Updated: 10/25/2017
A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy
Updated: 10/25/2017
Is Autologous Umbilical Cord Blood Reinfusion Beneficial in Children With Cerebral Palsy: A Randomized, Blinded, Placebo-Controlled, Crossover Study
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
Early Nurse Detection and Management of Delirium
Updated: 10/25/2017
Early Nurse Detection of Delirium Superimposed on Dementia
Status: Enrolling
Updated: 10/25/2017
Early Nurse Detection and Management of Delirium
Updated: 10/25/2017
Early Nurse Detection of Delirium Superimposed on Dementia
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
Early Nurse Detection and Management of Delirium
Updated: 10/25/2017
Early Nurse Detection of Delirium Superimposed on Dementia
Status: Enrolling
Updated: 10/25/2017
Early Nurse Detection and Management of Delirium
Updated: 10/25/2017
Early Nurse Detection of Delirium Superimposed on Dementia
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders
Updated: 10/25/2017
Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders
Status: Enrolling
Updated: 10/25/2017
Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders
Updated: 10/25/2017
Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety
Updated: 10/25/2017
Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety
Status: Enrolling
Updated: 10/25/2017
Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety
Updated: 10/25/2017
Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
The Use of Hyperbaric Oxygen to Increase the Blood Supply in the Injured, But Still Alive Tissue, Around an Old Stroke
Updated: 10/25/2017
Hyperbaric Oxygen in the Reduction of Post Stroke Ischemic Penumbra
Status: Enrolling
Updated: 10/25/2017
The Use of Hyperbaric Oxygen to Increase the Blood Supply in the Injured, But Still Alive Tissue, Around an Old Stroke
Updated: 10/25/2017
Hyperbaric Oxygen in the Reduction of Post Stroke Ischemic Penumbra
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS
Updated: 10/25/2017
Ferumoxytol-enhanced Imaging and Quantitative Susceptibility Mapping in neuroAIDS
Status: Enrolling
Updated: 10/25/2017
Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS
Updated: 10/25/2017
Ferumoxytol-enhanced Imaging and Quantitative Susceptibility Mapping in neuroAIDS
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS
Updated: 10/26/2017
Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS
Status: Enrolling
Updated: 10/26/2017
Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS
Updated: 10/26/2017
Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS
Status: Enrolling
Updated: 10/26/2017
Click here to add this to my saved trials
Evaluation of a Skill-Building, Supportive, and Educational Intervention for Couples
Updated: 10/26/2017
Evaluation of a Skill-Building, Supportive, and Educational Intervention for Couples (a Research Project Within the Traumatic Brain Injury Model System Grant)
Status: Enrolling
Updated: 10/26/2017
Evaluation of a Skill-Building, Supportive, and Educational Intervention for Couples
Updated: 10/26/2017
Evaluation of a Skill-Building, Supportive, and Educational Intervention for Couples (a Research Project Within the Traumatic Brain Injury Model System Grant)
Status: Enrolling
Updated: 10/26/2017
Click here to add this to my saved trials
Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease
Updated: 10/26/2017
The Effect of Hyperbaric Oxygen on the Functional Connectivity of Resting State Neural Networks in Patients With Cerebral Small Vessel Disease
Status: Enrolling
Updated: 10/26/2017
Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease
Updated: 10/26/2017
The Effect of Hyperbaric Oxygen on the Functional Connectivity of Resting State Neural Networks in Patients With Cerebral Small Vessel Disease
Status: Enrolling
Updated: 10/26/2017
Click here to add this to my saved trials
Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease
Updated: 10/26/2017
The Effect of Hyperbaric Oxygen on the Functional Connectivity of Resting State Neural Networks in Patients With Cerebral Small Vessel Disease
Status: Enrolling
Updated: 10/26/2017
Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease
Updated: 10/26/2017
The Effect of Hyperbaric Oxygen on the Functional Connectivity of Resting State Neural Networks in Patients With Cerebral Small Vessel Disease
Status: Enrolling
Updated: 10/26/2017
Click here to add this to my saved trials
Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease
Updated: 10/26/2017
The Effect of Hyperbaric Oxygen on the Functional Connectivity of Resting State Neural Networks in Patients With Cerebral Small Vessel Disease
Status: Enrolling
Updated: 10/26/2017
Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease
Updated: 10/26/2017
The Effect of Hyperbaric Oxygen on the Functional Connectivity of Resting State Neural Networks in Patients With Cerebral Small Vessel Disease
Status: Enrolling
Updated: 10/26/2017
Click here to add this to my saved trials
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
Updated: 10/26/2017
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
Status: Enrolling
Updated: 10/26/2017
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
Updated: 10/26/2017
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
Status: Enrolling
Updated: 10/26/2017
Click here to add this to my saved trials
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
Updated: 10/26/2017
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
Status: Enrolling
Updated: 10/26/2017
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
Updated: 10/26/2017
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
Status: Enrolling
Updated: 10/26/2017
Click here to add this to my saved trials
Efficacy of Statins In Prevention of CIN
Updated: 10/27/2017
Efficacy Of Statins In The Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Insufficiency (SCIN Trial): A Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 10/27/2017
Efficacy of Statins In Prevention of CIN
Updated: 10/27/2017
Efficacy Of Statins In The Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Insufficiency (SCIN Trial): A Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 10/27/2017
Click here to add this to my saved trials
Efficacy of Statins In Prevention of CIN
Updated: 10/27/2017
Efficacy Of Statins In The Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Insufficiency (SCIN Trial): A Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 10/27/2017
Efficacy of Statins In Prevention of CIN
Updated: 10/27/2017
Efficacy Of Statins In The Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Insufficiency (SCIN Trial): A Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 10/27/2017
Click here to add this to my saved trials
Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension
Updated: 10/27/2017
A Multicenter, Double Blind, Randomized, Placebo-Controlled Trial to Determine the Efficacy and Safety of Ganaxolone as Adjunctive Therapy for Adults With Drug-Resistant Partial-Onset Seizures Followed by Long-term Open-Label Treatment
Status: Enrolling
Updated: 10/27/2017
Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension
Updated: 10/27/2017
A Multicenter, Double Blind, Randomized, Placebo-Controlled Trial to Determine the Efficacy and Safety of Ganaxolone as Adjunctive Therapy for Adults With Drug-Resistant Partial-Onset Seizures Followed by Long-term Open-Label Treatment
Status: Enrolling
Updated: 10/27/2017
Click here to add this to my saved trials
Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension
Updated: 10/27/2017
A Multicenter, Double Blind, Randomized, Placebo-Controlled Trial to Determine the Efficacy and Safety of Ganaxolone as Adjunctive Therapy for Adults With Drug-Resistant Partial-Onset Seizures Followed by Long-term Open-Label Treatment
Status: Enrolling
Updated: 10/27/2017
Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension
Updated: 10/27/2017
A Multicenter, Double Blind, Randomized, Placebo-Controlled Trial to Determine the Efficacy and Safety of Ganaxolone as Adjunctive Therapy for Adults With Drug-Resistant Partial-Onset Seizures Followed by Long-term Open-Label Treatment
Status: Enrolling
Updated: 10/27/2017
Click here to add this to my saved trials